{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:23:38Z","timestamp":1786123418120,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1213\/ane.0b013e3181931737","type":"journal-article","created":{"date-parts":[[2009,2,13]],"date-time":"2009-02-13T03:28:59Z","timestamp":1234495739000},"page":"790-792","source":"Crossref","is-referenced-by-count":36,"title":["Treatment of Serious Calcium Channel Blocker Overdose With Levosimendan, a Calcium Sensitizer"],"prefix":"10.1213","volume":"108","author":[{"given":"Tero","family":"Varpula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Rapola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Sallisalmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouni","family":"Kurola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210902","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0002-9343(93)90314-F","article-title":"Verapamil intoxication: a literature review of overdoses and discussion of therapeutic options.","volume":"95","author":"Hofer","year":"1993","journal-title":"Am J Med"},{"key":"R2-21-20210902","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/15563650500357404","article-title":"Calcium channel blocker ingestion: an evidence-based consensus guideline for out-of-hospital management.","volume":"43","author":"Olson","year":"2005","journal-title":"Clin Toxicol"},{"key":"R3-21-20210902","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/bmj.308.6935.992","article-title":"Treating overdose with calcium channel blockers.","volume":"308","author":"Kenny","year":"1994","journal-title":"BMJ"},{"key":"R4-21-20210902","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.2146\/ajhp060041","article-title":"Treatment of poisoning caused by beta-adrenergic and calcium-channel blockers.","volume":"63","author":"Shepherd","year":"2006","journal-title":"Am J Health Syst Pharm"},{"key":"R5-21-20210902","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/j.1399-6576.2005.00709.x","article-title":"Severe poisoning with sotalol and verapamil. Recovery after 4 h of normothermic CPR followed by extra corporeal heart lung assist.","volume":"49","author":"Rygnestad","year":"2005","journal-title":"Acta Anaesthesiol Scand"},{"key":"R6-21-20210902","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.2165\/00003495-200363230-00009","article-title":"Levosimendan: a review of its use in the management of acute decompensated heart failure.","volume":"63","author":"Innes","year":"2003","journal-title":"Drugs"},{"key":"R7-21-20210902","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1161\/01.CIR.98.20.2141","article-title":"Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium.","volume":"98","author":"Hasenfuss","year":"1998","journal-title":"Circulation"},{"key":"R8-21-20210902","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/0022-2828(95)90009-8","article-title":"Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan.","volume":"27","author":"Haikala","year":"1995","journal-title":"J Mol Cell Cardiol"},{"key":"R9-21-20210902","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00005344-199505000-00016","article-title":"Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation.","volume":"25","author":"Haikala","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"R10-21-20210902","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/01.ccx.0000145099.20822.19","article-title":"ATP-dependent potassium channels as a key target for the treatment of myocardial and vascular dysfunction.","volume":"10","author":"Pollesello","year":"2004","journal-title":"Curr Opin Crit Care"},{"key":"R11-21-20210902","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1213\/01.ane.0000278146.15671.03","article-title":"The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.","volume":"105","author":"Stehr","year":"2007","journal-title":"Anesth Analg"},{"key":"R12-21-20210902","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.lab.2005.07.005","article-title":"Levosimendan improves postresuscitation outcomes in a rat model of CPR.","volume":"146","author":"Huang","year":"2005","journal-title":"J Lab Clin Med"},{"key":"R13-21-20210902","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.CCM.0000156241.55872.15","article-title":"Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction.","volume":"33","author":"Huang","year":"2005","journal-title":"Crit Care Med"},{"key":"R14-21-20210902","first-page":"1","article-title":"Treatment of experimental verapamil poisoning with levosimendan utilizing a rodent model of drug toxicity.","author":"Graudins","year":"2007","journal-title":"Clin Toxicol"},{"key":"R15-21-20210902","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1053\/euhj.2001.3158","article-title":"Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction: randomized, placebo-controlled, double-blind study (RUSSLAN).","volume":"23","author":"Moiseyev","year":"2002","journal-title":"Eur Heart J"},{"key":"R16-21-20210902","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1081\/CLT-120023761","article-title":"Glucagon in beta-blocker and calcium channel blocker overdoses: a systematic review.","volume":"41","author":"Bailey","year":"2003","journal-title":"J Toxicol Clin Toxicol"},{"key":"R17-21-20210902","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/cc4938","article-title":"Bench-to-bedside review: hyperinsulinaemia\/euglycaemia therapy in the management of overdose of calcium-channel blockers.","volume":"10","author":"Lheureux","year":"2006","journal-title":"Crit Care"},{"key":"R18-21-20210902","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/15563650600795669","article-title":"The use of vasopressin in the setting of recalcitrant hypotension due to calcium channel blocker overdose.","volume":"45","author":"Kanagarajan","year":"2007","journal-title":"Clin Toxicol"}],"container-title":["Anesthesia & Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ane.0b013e3181931737","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:24:36Z","timestamp":1786112676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-200903000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e3181931737","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}